Middle East and Africa Asthma Spacers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Aerochamber, Optichamber, Volumatic, and Inspirease) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce)

List of Tables

The asthma spacers market in MEA is expected to grow from US$ 50.92 million in 2022 to US$ 61.42 million by 2028; it is estimated to grow at a CAGR of 3.2% from 2022 to 2028.

Chronic respiratory conditions becoming more prevalent is the major factor driving the growth of the MEA asthma spacers market. Asthma causes swellings in airways passages, narrowing airways to the lungs and further causing trouble breathing, tightness in the chest, wheezing, and other associated indications. Chronic obstructive pulmonary disease (COPD) also causes obstructions in airflow. The causes of these conditions are unclear; however, genetic factors, environmental conditions, overweight conditions, and smoking are major risk factors.

Government authorities and healthcare institutions are implementing various programs to increase asthma awareness and prevent disease morbidity. The National Asthma Control Program (NACP), launched by the Centers for Disease Control and Prevention, is working continually to increase awareness regarding asthma and curb the disease. The program is dedicated to conducting asthma surveillance and research to deal with the disease. Such programs are boosting the adoption of inhalers, which are, in turn, driving the market. Also, the MEA region is experiencing decent growth in the number of industries, including medical, demanding advanced products and solutions. This factor boosts the asthma spacers market in the region. Also, the steady growth in the levels of pollution coupled with constantly changing lifestyles in the region. Moreover, the growing prevalence of respiratory disorders also creates a huge demand for the region's asthma spacers market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA asthma spacers market. The MEA asthma spacers market is expected to grow at a good CAGR during the forecast period.

MEA Asthma Spacers Market Revenue and Forecast to 2028 (US$ Million)

MEA Asthma Spacers Market Segmentation

The MEA asthma spacers market is segmented into product, distribution channel, and country. Based on product, the MEA asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. In 2022, the aerochamber is expected to hold the largest market share and is expected to witness the highest CAGR from 2022 to 2028. Based on distribution channel, the MEA asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and E-commerce. The retail pharmacy segment is expected to hold the largest share of the market in 2022. Based on country, the MEA asthma spacers market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the MEA. The rest of the MEA held the largest market share in 2022.

Agaplastic, Cipla Inc., Koninklijke Philips N.V., Koo Medical Equipment, Lupin, Metall Zug, and Teleflex Incorporated are among the leading companies in the asthma spacers market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA asthma spacers market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA asthma spacers market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the asthma spacers market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025512

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 MEA Asthma Spacers Market - By Product
- 1.3.2 MEA Asthma Spacers Market - By Distribution Channel
- 1.3.3 MEA Asthma Spacers Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Asthma Spacers Market - Market Landscape

4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion

5. MEA Asthma Spacers Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Chronic Respiratory Conditions Becoming More Common
- 5.1.2 Improving Consciousness Regarding Benefits of Spacers
5.2 Market Restraints
- 5.2.1 Increased Risk of Adverse Effects due to Unlicensed Prescriptions
5.3 Future Trends
- 5.3.1 Patient-Centric Spacer Design Given Importance
5.4 Impact Analysis

6. Asthma Spacers Market- MEA Analysis

6.1 MEA Asthma Spacers Market Revenue Forecast and Analysis
6.2 MEA: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)

7. MEA Asthma Spacers Market Revenue and Forecast To 2028 - by Product

7.1 Overview
7.2 MEA Asthma Spacers Market, by Products, 2022 & 2028 (% Share)
7.3 Aerochamber
- 7.3.1 Overview
- 7.3.2 Aerochamber Revenue and Forecast to 2028 (US$ Mn)
7.4 Optichamber
- 7.4.1 Overview
- 7.4.2 Optichamber Revenue and Forecast to 2028 (US$ Mn)
7.5 Volumatic
- 7.5.1 Overview
- 7.5.2 Volumatic Revenue and Forecast to 2028 (US$ Mn)
7.6 Inspirease
- 7.6.1 Overview
- 7.6.2 Inspirease Revenue and Forecast to 2028 (US$ Mn)

8. MEA Asthma Spacers Market Analysis and Forecast to 2028 - by Distribution Channel

8.1 Overview
8.2 MEA Asthma Spacers Market, by Products, 2022 & 2028 (% Share)
8.3 Hospital Pharmacy
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Retail Pharmacy
- 8.4.1 Overview
- 8.4.2 Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)
8.5 E-Commerce
- 8.5.1 Overview
- 8.5.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Mn)

9. MEA Asthma Spacers Market Revenue and Forecasts to 2028 - Country Analysis

9.1 Overview
- 9.1.1 MEA: Asthma Spacers Market, by Country, 2022 & 2028 (%)
  - 9.1.1.1 Saudi Arabia: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.1.1 Saudi Arabia: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.1.2 Saudi Arabia: Asthma Spacers Market, by Product, 2019-2028 (USD Million)
    - 9.1.1.1.3 Saudi Arabia: Asthma Spacers Market, by Distribution Channel, 2019-2028 (USD Million)
  - 9.1.1.2 South Africa: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.2.1 South Africa: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.2.2 South Africa: Asthma Spacers Market, by Product, 2019-2028 (USD Million)
    - 9.1.1.2.3 South Africa: Asthma Spacers Market, by Distribution Channel, 2019-2028 (USD Million)
  - 9.1.1.3 UAE: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.3.1 UAE: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.3.2 UAE: Asthma Spacers Market, by Product, 2019-2028 (USD Million)
    - 9.1.1.3.3 UAE: Asthma Spacers Market, by Distribution Channel, 2019-2028 (USD Million)
  - 9.1.1.4 Rest of the MEA: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.4.1 Rest of the MEA: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.1.4.2 Rest of the MEA: Asthma Spacers Market, by Product, 2019-2028 (USD Million)
    - 9.1.1.4.3 Rest of the MEA: Asthma Spacers Market, by Distribution Channel, 2019-2028 (USD Million)

10. Asthma Spacers Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies Done by the Companies in the Market (%)
10.3 Organic Developments
- 10.3.1 Overview
10.4 Inorganic Developments
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Inc.
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Koninklijke Philips N.V.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Lupin
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Koo Medical Equipment
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Agaplastic
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Teleflex Incorporated
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Metall Zug AG
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms